comparemela.com
Home
Live Updates
Anti Pd 1 - Breaking News
Pages:
2
3
4
5
6
7
8
Anti Pd 1 News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Treating Patients with High-Risk Melanoma
A comprehensive overview of treatment approaches for patients with high-risk melanoma.
Nikhil khushalani
Annac pavlick
Sunandana chandra
Unresectable metastatic melanoma
High risk melanoma
Anti pd 1
Braf mek
Stage iii disease
Resected stage iv
Targeted therapy
Tumor-Directed Oncolytic Therapies for Melanoma and CSCC
An expert panel discusses the use of tumor-directed oncolytic therapies for melanoma and cutaneous squamous cell carcinoma.
Nikhil khushalani
Sunandana chandra
Cutaneous squamous cell carcinoma
Unresectable metastatic melanoma
Tumor directed oncolytic therapies
T vec
Anti pd 1
Intralesional therapy
Deciding Between Melanoma Therapy Options
A panel of skin cancer experts share their thoughts on treatment selection for patients with melanoma.
Sunandana chandra
Annac pavlick
Nikhil khushalani
Unresectable metastatic melanoma
Combination immunotherapy
Anti pd 1
Braf mutations
Triplet therapy
Braf mek inhibitor
Checkmate 067
BRAF/MEK Dual Inhibitors for Melanoma
An expert panel analyzes BRAF/MEK dual inhibitor therapy for the treatment of melanoma.
Sunandana chandra
Nikhil khushalani
Clinical oncology
Unresectable metastatic melanoma
Dreamseq trial
Combination immunotherapy
Braf mek
Targeted therapy
Second line treatment
Anti pd 1
Anti ctla4
Braf mutation
Map kinase
Factors that Impact Treatment Selection for Melanoma
Anna C. Pavlick, DO, discusses factors that impact treatment selection for patients with melanoma.
Sunandana chandra
Annac pavlick
Unresectable metastatic melanoma
Performance status
Disease burden
Braf mutation
Dreamseq trial
Anti pd 1
Anti ctla4
Mutation status
Targeted therapy
vimarsana © 2020. All Rights Reserved.